⌘K

Home/Filings/4/0001493152-24-033618

4//SEC Filing

Chen Ivan 4

Accession 0001493152-24-033618

CIK 0001006028other

View on SEC.gov Company Profile

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 5:56 PM ET

Size

5.8 KB

Accession

0001493152-24-033618

Insider Transaction Report

Form 4

Period: 2024-08-20

PURE BIOSCIENCE, INC.PURE

Director

Transactions

Award
Stock Option (Right to Buy)
2024-08-20+150,000→ 150,000 total
Exercise: $0.07Exp: 2034-08-20→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of January 15, 2025 or the date of the Issuer's annual meeting of stockholders held in 2025, and (ii) 50% of the options will vest on the earlier of January 15, 2026 or the date of the Issuer's annual meeting of stockholders held in 2026.

Documents

1 file

4
ownership.xmlPrimary

Issuer

PURE BIOSCIENCE, INC.

CIK 0001006028

Entity typeother

Related Parties

1

filerCIK 0001743729

Filing Metadata

Form type: 4
Filed: Aug 21, 8:00 PM ET
Accepted: Aug 22, 5:56 PM ET
Size: 5.8 KB

View on SEC.gov